In recent years there has been an increase in multi-drug resistance (MDR) amongst gram-positive pathogens. This has impacted both hospital and community acquired infections.
Micronaut-S板设计为常规实验室提供有效的工具,用于表型检测这些细菌中重要的抗性机制。Micronaut-S MRSA/GP还包括高效的备用抗生素:头孢霉菌,Daptomycin,lineZolid,Tigecycline,Tigecycline,Vancomycin和Teicoplanin。
The susceptibility testing is based on the rehydration of antibiotics by adding a standardized bacteria suspension (Mueller Hinton Broth, cation adjusted (CAMHB)). The result is measured photometrically after 18-24 hours incubation at 35-37°C. Results are measured and interpreted either with the MICRONAUT software or visually.
由于一种特殊的真空干燥方法,板可以在15-25°C的室温下储存。生产日期,微毛测试板的保质期为24个月。
Micronaut-S MRSA/GP板的抗生素构型允许特异性检测革兰氏阳性细菌在医院感染中的临床相关单或多抗性。
The susceptibility testing with highly effective reserve antibiotics like ceftaroline offers the user alternatives in case of extreme multi-resistance. The MICRONAUT-S MRSA/GP offers the following features and benefits.
请联系您当地的代表以获取您所在国家的可用性。
不是为了sale in the USA. MERLIN Gesellschaft für mikrobiologische Diagnostika mbH – A Bruker Company (www.merlin-diagnostika.de)